Gabapentin is frequently used as an analgesic in patients with chronic kidney disease. Although gabapentin is well known for its favorable pharmacokinetics, it is exclusively eliminated renally, and patients with chronic kidney disease are at risk for toxicity. Existing literature on such risk is lacking. The short answer is: yes, gabapentin can be problematic for individuals with kidney failure and chronic kidney disease (CKD). While gabapentin is often prescribed for pain management, particularly nerve pain, and sometimes for seizures, its primary elimination pathway is through the kidneys. Pain is one of the most common and distressing symptoms for people with chronic kidney disease (CKD). Take care when choosing a painkiller (analgesic) as some types should not be taken by people with kidney problems or should only be used with specialist guidance. Patients with chronic kidney disease often receive inappropriately high gabapentin dosage for their kidney function, occasioning overt toxicity; advanced age and comorbidity predispose these patients for toxicity. Majority drugs, including Gabapentin, are eliminated by the kidneys and will accumulate to a toxic level in renally compromised patients as in this case. Per Lexicomp, Gabapentin’s recommended dose in patients with renal impairment is as follows: CrCl >15 to 29 mL/minute: 200 to 700 mg once daily. CrCl 15 mL/minute: 100 to 300 mg once daily Gabapentin and pregabalin are commonly used for neuropathic pain in CKD patients but are not fully understood as this population remains excluded from efficacy and safety trials. Renal adjustments for the gabapentinoids are prodigiously recommended in the literature. NSAIDs have the most potential for risk when it comes to your kidneys. The best pain med for you depends on a variety of factors, including kidney health. Let's discuss: The straightforward answer is yes, you can potentially take gabapentin if you have stage 3 kidney disease, but with significant caveats. It’s crucial to understand that gabapentin is primarily eliminated by the kidneys, meaning that impaired kidney function can lead to a buildup of the drug in your system. Many analgesics that are typically used in the non-CKD population should not be used among patients with advanced CKD (ie, estimated glomerular filtration rate [eGFR] <30 mL/min/1.73 m 2; including those on dialysis). This topic reviews the epidemiology, assessment of pain, and management of pain among patients with advanced CKD. Gabapentinoids are eliminated from the body solely by the kidney, and pharmacokinetic studies show a stepwise prolongation in the elimination half-life of gabapentin and pregabalin as kidney function declines. 9, 10 Gabapentinoids should therefore be started at lower doses in patients with chronic kidney disease (CKD; guidelines are summarized with chronic kidney disease often receive inappropriately high gabapentin dosage for their kidney function, occasioning overt toxicity; advanced age and comorbidity predispose these patients for toxicity. If you have diabetes and chronic kidney disease, check with your physician to see if any dosing changes need to be made based on your level of kidney function. Upset stomach/antacid medications. This group of over-the-counter medications can disrupt the body's electrolyte balance if you have chronic kidney disease. We found that patients with chronic kidney disease had elevated serum gabapentin concentrations, in some cases leading to gabapentin toxicity; those with advanced age and multiple comorbidities were more prone to the toxicity, and the toxicity tended to be underrecognized. Background: Gabapentinoids (GPs) are frequently prescribed in individuals with chronic kidney disease (CKD); however, their exclusive renal elimination warrants dose adjustments to decrease risk of toxicity. This study evaluated GP prescribing patterns and whether excessive dosing was associated with increased incidence of gabapentinoid-related Patients with chronic kidney disease often receive dangerously high gabapentin dosage for their kidney function, which can lead to all sorts of problems. An alternative we recommend instead of Gabapentin is Alpha Lipoic Acid. Gabapentin (Neurontin) usually isn’t bad for your liver or kidneys. In most cases, it has little effect on these organs. In rare instances, gabapentin can cause DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome. Chronic Kidney Disease Randy Chen, M.D. Thanks to our speaker! Randy Chen, M.D. –Practicing nephrologist Gabapentin •Very commonly prescribed for nerve pain. Challenges in pain management in patients with kidney disease. Pain assessment. This should start with assessment of a) pain severity using various standardized tools, most common of which is the numerical rating scale []; b) pathophysiologic evaluatio n into mechanism of injury and type of pain; c) psychosocial evaluation of co-occurring factors that contribute to pain or make treatment of Gabapentin is not absolutely contraindicated in kidney disease, but it demands meticulous management. The key to its safe use is careful dose adjustments, rigorous monitoring for toxicity, and an open dialogue with your healthcare provider.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |